Eli Lilly and Company
@EliLillyandCo
Followers
143K
Following
2K
Statuses
22K
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad) https://t.co/oXewUD8FZI
Indianapolis, IN
Joined July 2010
Lilly insulin is $35 or less a month. And the latest changes we’ve made to our insulin affordability solutions make it easier to access. Learn more:
167
22
58
@stacy1250 Your question is important, thank you for contacting Lilly. Due to the nature of our highly regulated industry, we are unable to discuss certain topics here. Please call the Lilly Answer Center at 1-800-Lilly-Rx to connect with us.
0
0
1
See long-term response and remission data over two years for patients with moderately to severely active #CrohnsDisease treated with our FDA approved medication. Explore the data presented at #CCCongress25:
0
1
6
In 2024, our medicines gave millions more people a chance at better health. Read more about our Q4 2024 results:
0
2
12
@SlothsPink Your question is important, thank you for contacting Lilly. Due to the nature of our highly regulated industry, we are unable to discuss certain topics here. Please call the Lilly Answer Center at 1-800-Lilly-Rx to connect with us.
2
0
1
@AmyHogan11 Hello Amy, Your question is important, thank you for contacting Lilly. Due to the nature of our highly regulated industry, we are unable to discuss certain topics here. Please call the Lilly Answer Center at 1-800-Lilly-Rx to connect with us.
0
0
0
@OnyxVegan Hello, thank you for your interest in joining Lilly. To learn more about our company and all of the amazing opportunities worldwide, visit
0
1
4
Pioneering better medicines means more people get the right medicines. This collaboration with @LifeAtPurdue and @Merck aims to revolutionize how we make medicines—so more people have a chance at better health. #WeAreLilly
#Purdue aims to speed the evolution of pharmaceutical manufacturing in collaboration with @EliLillyandCo and @Merck, developing groundbreaking advances in injectable medicines.
5
1
16
News for people living with moderately to severely active #CrohnsDisease: the @US_FDA has approved a new treatment option for adults living with this chronic inflammatory bowel disease:
2
3
11
Our scientists continue exploring new approaches to breast cancer. Today we announced an agreement to acquire an innovative clinical program from Scorpion Therapeutics.
3
2
14
If you live with a chronic condition such as obesity, psoriasis or psoriatic arthritis, we know how important it is to get the medicines you need. Learn more about steps we’re taking to help. #WeAreLilly
5
3
11
Learn more about a new treatment option for moderate-to-severe obstructive sleep apnea and obesity:
5
10
19
New data presented at #SABCS24 demonstrate positive results in people with ER+, HER2- advanced or metastatic breast cancer (MBC). Read more about the potential impact:
1
4
16
@essentlyStacey We recognize that patients and their families need support and information to navigate their health journeys. Lilly and other organizations provide a number of resources that may help:
1
0
1
New results presented at #ASH24 from the first of our Phase 3 randomized trials for people living with certain blood cancers are promising for those with chronic lymphocytic leukemia or small lymphocytic lymphoma. Learn more:
3
4
13
We welcome the ADA’s guidance against unapproved compounded medicines, which rightly points out the “uncertainty about their content, safety, quality, and effectiveness.” No patient should be exposed to unapproved knockoff drugs with heightened risks.
Today, the American Diabetes Association® issued a statement against using non-FDA approved compounded GLP-1 and dual GIP/GLP-1 RA products. Safety, quality, and effectiveness may be at risk. Read more at
11
3
13
Today’s announcement—a $3B manufacturing expansion in Kenosha County, Wisconsin—is our largest U.S. manufacturing investment outside of Indiana. This will help meet the growing demand for our diabetes, obesity and other future medicines. #WeAreLilly
5
8
36
News today: initial results from a head-to-head clinical trial comparing two treatments for adults living with obesity or overweight. Learn more:
4
5
17